Concepts (56)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fluconazole | 1 | 2010 | 7 | 0.320 |
Why?
|
| Mycoses | 1 | 2010 | 19 | 0.320 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2010 | 17 | 0.320 |
Why?
|
| Antifungal Agents | 1 | 2010 | 36 | 0.320 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2010 | 26 | 0.320 |
Why?
|
| Rheumatic Fever | 1 | 2012 | 3 | 0.090 |
Why?
|
| Streptococcus pyogenes | 1 | 2012 | 4 | 0.090 |
Why?
|
| Macrolides | 1 | 2012 | 6 | 0.090 |
Why?
|
| Pharyngitis | 1 | 2012 | 7 | 0.090 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2012 | 52 | 0.090 |
Why?
|
| Brucella | 1 | 2011 | 3 | 0.090 |
Why?
|
| Brucellosis | 1 | 2011 | 4 | 0.090 |
Why?
|
| Bacteremia | 1 | 2011 | 98 | 0.080 |
Why?
|
| Cholestasis | 1 | 2010 | 7 | 0.080 |
Why?
|
| Candidiasis | 1 | 2010 | 23 | 0.080 |
Why?
|
| Infant, Premature, Diseases | 1 | 2010 | 26 | 0.080 |
Why?
|
| Infant, Premature | 1 | 2010 | 186 | 0.070 |
Why?
|
| Urticaria | 1 | 2008 | 4 | 0.070 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2008 | 5 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 362 | 0.070 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2010 | 172 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2010 | 535 | 0.070 |
Why?
|
| Male | 5 | 2012 | 12438 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2010 | 2940 | 0.050 |
Why?
|
| Adolescent | 3 | 2012 | 1877 | 0.040 |
Why?
|
| Female | 3 | 2012 | 12935 | 0.040 |
Why?
|
| Humans | 5 | 2012 | 22913 | 0.040 |
Why?
|
| Child | 2 | 2012 | 1156 | 0.030 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 1997 | 1 | 0.030 |
Why?
|
| Keratitis, Herpetic | 1 | 1997 | 1 | 0.030 |
Why?
|
| Acyclovir | 1 | 1997 | 4 | 0.030 |
Why?
|
| Herpesvirus 1, Human | 1 | 1997 | 2 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 1997 | 66 | 0.030 |
Why?
|
| Ethylenediamines | 1 | 2012 | 5 | 0.020 |
Why?
|
| Penicillins | 1 | 2012 | 9 | 0.020 |
Why?
|
| Streptococcal Infections | 1 | 2012 | 9 | 0.020 |
Why?
|
| Splenomegaly | 1 | 2011 | 6 | 0.020 |
Why?
|
| Milk | 1 | 2011 | 11 | 0.020 |
Why?
|
| Mexico | 1 | 2011 | 14 | 0.020 |
Why?
|
| Hepatomegaly | 1 | 2011 | 7 | 0.020 |
Why?
|
| Travel | 1 | 2011 | 14 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2012 | 126 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 163 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 162 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 268 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2011 | 566 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 547 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 800 | 0.020 |
Why?
|
| Chicago | 1 | 2011 | 813 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 1413 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2008 | 375 | 0.020 |
Why?
|
| Risk Factors | 1 | 2011 | 1968 | 0.020 |
Why?
|
| Animals | 1 | 2011 | 3293 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2011 | 2994 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1997 | 66 | 0.010 |
Why?
|
| Adult | 1 | 1997 | 6912 | 0.000 |
Why?
|